183 related articles for article (PubMed ID: 9123375)
1. Modulation of anti-HLA antibody production following renal transplantation in sensitised, immunoadsorbed patients.
Bevan DJ; Carey BS; Vaughan RW; Fallon M; Higgins RM; Hendry BM; Bewick M
Transplant Proc; 1997; 29(1-2):1448. PubMed ID: 9123375
[No Abstract] [Full Text] [Related]
2. Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients.
Fuggle SV; Martin S
Transplantation; 2008 Aug; 86(3):384-90. PubMed ID: 18698240
[TBL] [Abstract][Full Text] [Related]
3. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
4. Immunoadsorption in acute vascular rejection after renal transplantation.
Persson NH; Bucin D; Ekberg H; Källén R; Omnell Persson M; Simanaitis M; Sterner G; Swedenborg P
Transplant Proc; 1995 Dec; 27(6):3466. PubMed ID: 8540054
[No Abstract] [Full Text] [Related]
5. The presence of donor-specific antibodies in renal transplantation.
Tozkir H; Sağiroğlu T; Kiliçarslan-Ayna T; Tan S; Çopuroğlu E; Sağiroğlu G; Sari G; Gürkan H; Sezer A
Transplant Proc; 2012; 44(6):1667-9. PubMed ID: 22841240
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of flow cytometry before and after renal transplantation.
van Hooff JP; Christiaans MH; van den Berg-Loonen PM
Transplant Proc; 1999 Dec; 31(8):3352. PubMed ID: 10616503
[No Abstract] [Full Text] [Related]
7. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
[TBL] [Abstract][Full Text] [Related]
8. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
9. Sensitization to HLA antigens occurs in 95% of primary renal transplant rejections.
Harmer AW; Koffman CG; Heads AJ; Vaughan RW
Transplant Proc; 1995 Feb; 27(1):666-7. PubMed ID: 7879137
[No Abstract] [Full Text] [Related]
10. Role of crossmatch testing when Luminex-SAB is negative in renal transplantation.
Jayant K; Reccia I; Julie BM; Sharma A; Halawa A
Pol Przegl Chir; 2018 Feb; 90(1):41-46. PubMed ID: 29513250
[TBL] [Abstract][Full Text] [Related]
11. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ
Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237
[TBL] [Abstract][Full Text] [Related]
12. Poor graft survival in patients historically positive for antidonor antibody after living related renal transplantations.
Nanri M; Tanabe K; Ishida H; Tokumoto T; Shinmura H; Toma H
Transplant Proc; 2002 Aug; 34(5):1583. PubMed ID: 12176494
[No Abstract] [Full Text] [Related]
13. Effect of HLA semi-identical pretransplant blood transfusions on renal allograft outcome.
Mariat C; Alamartine E; De Filippis JP; Deprele C; Le Petit JC; Goure D; Berthoux F
Transplant Proc; 2000 Mar; 32(2):381-3. PubMed ID: 10715446
[No Abstract] [Full Text] [Related]
14. Compared effects of random and one HLA semi-identical transfusions on alloimmunization and acute rejection episodes in first renal allograft recipients.
Vérove C; Jollet I; Lobbedez T; Dumont G; Griveau AM; Hurault de Ligny B; Alcalay D; Touchard G
Transplant Proc; 1998 Sep; 30(6):2863-4. PubMed ID: 9745601
[No Abstract] [Full Text] [Related]
15. Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation.
Thiyagarajan UM; Bagul A; Frost J; Horsburgh T; Nicholson ML
Transplant Proc; 2012 Jun; 44(5):1231-5. PubMed ID: 22663991
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin induction treatment in flow cytometry cross-match-positive kidney transplant recipients.
Akalin E; Bromberg JS
Hum Immunol; 2005 Apr; 66(4):359-63. PubMed ID: 15866698
[TBL] [Abstract][Full Text] [Related]
17. Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation.
Palmer A; Taube D; Welsh K; Bewick M; Gjorstrup P; Thick M
Lancet; 1989 Jan; 1(8628):10-2. PubMed ID: 2563001
[TBL] [Abstract][Full Text] [Related]
18. Hidden perils in a highly sensitized kidney transplant recipient.
Ford S; Summers S; Cantwell L; Mulley W
Nephrology (Carlton); 2012 Apr; 17 Suppl 1():9-11. PubMed ID: 22497647
[TBL] [Abstract][Full Text] [Related]
19. Repeated mismatches may not impair survival of renal regrafts in recipients with 0% to 50% panel reactive antibodies.
Mjörnstedt L; Konar J; Skarp I; Olausson M; Sandberg L; Tufvesson G
Transplant Proc; 1992 Dec; 24(6):2469. PubMed ID: 1465834
[No Abstract] [Full Text] [Related]
20. Prognostic value and cost-effectiveness of different screening strategies for HLA antibodies prior to kidney transplantation.
Ziemann M; Schönemann C; Bern C; Lachmann N; Nitschke M; Fricke L; Görg S
Clin Transplant; 2012; 26(4):644-56. PubMed ID: 22432638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
